Polarisation of type III translocation by Pseudomonas aeruginosa requires PcrG, PcrV and PopN - PubMed (original) (raw)
Polarisation of type III translocation by Pseudomonas aeruginosa requires PcrG, PcrV and PopN
Charlotta Sundin et al. Microb Pathog. 2004 Dec.
Abstract
Type III secretion (TTS) mediated translocation of exoenzymes is a key virulence strategy utilised by the opportunistic pathogen Pseudomonas aeruginosa to deliver exoenzyme effectors into the eukaryotic cell. We have previously shown that type III mediated translocation is a contact dependent process, which requires the secreted translocator proteins PcrV, PopB and PopD. To further analyse this mechanism, HeLa cells were infected with the wild-type strain PAK as well as isogenic pcrV, popB, popD, pcrG and popN mutants. In the presence of eukaryotic cells, expression of exoenzyme S (ExoS) increased. When cells were infected with the wild-type strain PAK no ExoS was detected in the tissue culture medium. This confirms that ExoS translocation by P. aeruginosa occurs by a polarised mechanism. In contrast, high levels of ExoS were recovered in the tissue culture medium when cells were infected with pcrG, pcrV and popN mutants. Additionally, ExoS expression levels were higher for these mutants regardless of inducing conditions. This suggests that PcrG, PcrV and PopN are involved in negative regulation of ExoS expression and secretion, and are required to ensure polarised delivery of effectors into target cells.
Similar articles
- The V antigen of Pseudomonas aeruginosa is required for assembly of the functional PopB/PopD translocation pore in host cell membranes.
Goure J, Pastor A, Faudry E, Chabert J, Dessen A, Attree I. Goure J, et al. Infect Immun. 2004 Aug;72(8):4741-50. doi: 10.1128/IAI.72.8.4741-4750.2004. Infect Immun. 2004. PMID: 15271936 Free PMC article. - Type III secretion proteins PcrV and PcrG from Pseudomonas aeruginosa form a 1:1 complex through high affinity interactions.
Nanao M, Ricard-Blum S, Di Guilmi AM, Lemaire D, Lascoux D, Chabert J, Attree I, Dessen A. Nanao M, et al. BMC Microbiol. 2003 Oct 18;3:21. doi: 10.1186/1471-2180-3-21. BMC Microbiol. 2003. PMID: 14565848 Free PMC article. - Type IV pili are not specifically required for contact dependent translocation of exoenzymes by Pseudomonas aeruginosa.
Sundin C, Wolfgang MC, Lory S, Forsberg A, Frithz-Lindsten E. Sundin C, et al. Microb Pathog. 2002 Dec;33(6):265-77. doi: 10.1006/mpat.2002.0534. Microb Pathog. 2002. PMID: 12495673 - Pseudomonas aeruginosa ExoS and ExoT.
Barbieri JT, Sun J. Barbieri JT, et al. Rev Physiol Biochem Pharmacol. 2004;152:79-92. doi: 10.1007/s10254-004-0031-7. Epub 2004 Aug 24. Rev Physiol Biochem Pharmacol. 2004. PMID: 15375697 Review. - Role of Pseudomonas aeruginosa type III effectors in disease.
Engel J, Balachandran P. Engel J, et al. Curr Opin Microbiol. 2009 Feb;12(1):61-6. doi: 10.1016/j.mib.2008.12.007. Epub 2009 Jan 23. Curr Opin Microbiol. 2009. PMID: 19168385 Review.
Cited by
- Control of type III secretion activity and substrate specificity by the cytoplasmic regulator PcrG.
Lee PC, Zmina SE, Stopford CM, Toska J, Rietsch A. Lee PC, et al. Proc Natl Acad Sci U S A. 2014 May 13;111(19):E2027-36. doi: 10.1073/pnas.1402658111. Epub 2014 Apr 28. Proc Natl Acad Sci U S A. 2014. PMID: 24778208 Free PMC article. - Azithromycin Attenuates _Pseudomonas_-Induced Lung Inflammation by Targeting Bacterial Proteins Secreted in the Cultured Medium.
Leal T, Bergamini G, Huaux F, Panin N, Noel S, Dhooghe B, Haaf JB, Mauri P, Motta S, Di Silvestre D, Melotti P, Sorio C. Leal T, et al. Front Immunol. 2016 Nov 15;7:499. doi: 10.3389/fimmu.2016.00499. eCollection 2016. Front Immunol. 2016. PMID: 27895643 Free PMC article. - Protein export according to schedule: architecture, assembly, and regulation of type III secretion systems from plant- and animal-pathogenic bacteria.
Büttner D. Büttner D. Microbiol Mol Biol Rev. 2012 Jun;76(2):262-310. doi: 10.1128/MMBR.05017-11. Microbiol Mol Biol Rev. 2012. PMID: 22688814 Free PMC article. Review. - Efficient isolation of Pseudomonas aeruginosa type III secretion translocators and assembly of heteromeric transmembrane pores in model membranes.
Romano FB, Rossi KC, Savva CG, Holzenburg A, Clerico EM, Heuck AP. Romano FB, et al. Biochemistry. 2011 Aug 23;50(33):7117-31. doi: 10.1021/bi200905x. Epub 2011 Jul 26. Biochemistry. 2011. PMID: 21770428 Free PMC article. - Salicylidene Acylhydrazides and Hydroxyquinolines Act as Inhibitors of Type Three Secretion Systems in Pseudomonas aeruginosa by Distinct Mechanisms.
Anantharajah A, Buyck JM, Sundin C, Tulkens PM, Mingeot-Leclercq MP, Van Bambeke F. Anantharajah A, et al. Antimicrob Agents Chemother. 2017 May 24;61(6):e02566-16. doi: 10.1128/AAC.02566-16. Print 2017 Jun. Antimicrob Agents Chemother. 2017. PMID: 28396545 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases